CClinicalTrials.gg
CompletedNCT02573103Updated Jul 12, 2018

Air Pollution and Cardiovascular Disease

An observational study in Metabolic Disorder, sponsored by WeiHuang. Completed. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-07-12.

Sponsored by WeiHuang · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
73
Ages
18 Years to 50 Years
Sex
All
01

Study summary

To determine the effects of ambient airpollution exposures on cardiovascular responses among healthy adults without cardiovascular disease.

02

Conditions studied

  • Metabolic Disorder
03

In context

Cardiovascular Diseases

4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

This study's enrollment of 73 is below the median of 573 across 1,485 observational studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

WeiHuang is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

We will maintain enrollment criteria of the in-progress study being healthy adults without CV disease or risk factors

Inclusion criteria

  • without CV disease or risk factors (e.g., hypertension, diabetes, or treated hyperlipidemia). Subjects are non-smokers in non-smoking household.

Exclusion criteria

Exclusion Criteria:

  • Screening visit BP>140/90 mm Hg, fasting glucose >126 mg/dL, or positive urine pregnancy test (females). Subjects cannot be taking any medications or over-the-counter drugs that affect CV function.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
73 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. Dyslipidemia

    Analyzed HDL by Beckman AU5800

    Time frame: One year

Secondary outcomes

  1. System oxidative stress

    Analyzed oxidative stress biomarkers,such as MDA by HPLC

    Time frame: One year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 12, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02573103
Lead sponsor
WeiHuang
Responsible party
WeiHuang (Peking University School of Public Health, Peking University) — Sponsor-investigator
First posted
Oct 9, 2015
Start date
Nov 2014
Primary completion
Jan 2016
Completion
Jan 2016
Last update
Jul 12, 2018

Study contacts

Wei Huang, PhD
principal investigator · Peking University School of Public Health

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion